On the stock market since 2018, it operates in the world of health and science. It has 1,422 employees. Now — the numbers.
This is an established company with proven profits.
Average growth of 13% a year over the last 4 years. Red columns mark years that ended in a loss.
If every debt were paid off today, $10.4B would still be left in the vault — a solid cushion for hard times.
angles, checked one by one.
The 4 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
R&D Investment: Spending on future research is low.
An investor who bought at the very peak is down 62% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
There is $10.4B in the vault; even if every debt were paid off, $10.4B would remain.
The stock sits at $0.66. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
The share set aside for the future is small; the pace of new ideas may slow. Council score: 2/10.
The weight of investors positioned for a fall can be felt in the market. Council score: 2/10.
On our five-subject report card, ALBHF sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: ALBHF is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.